Armstrong Pharma Acquired by Medeva

	Armstrong Pharmaceuticals, Inc. (NASDAQ) is a leading producer of drug delivery systems including inhalation therapeutics devices
	Armstrong retained TM Capital as financial advisor in connection with Armstrong's $52 million stock swap merger with Medeva plc (LSE)
	TM Capital also provided a fairness opinion to the board of directors of Armstrong in connection with the merger with Medeva